Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.


Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

AcelRx appoints general counsel

Scuttlebutt | April 24, 2018

Pharmaceutical company AcelRx Pharmaceuticals announced the appointment of John Saia as general counsel, effective as of April 16.

Saia joins AcelRx from healthcare company McKesson, where he most recently served as corporate secretary and associate general counsel. At McKesson, he served in various roles with increasing responsibilities and leadership, which included leading and supporting nearly 100 acquisitions over this period.

Prior to McKesson, Saia was a senior attorney at DLA Piper, advising clients on capital markets transactions, public reporting, and M&A.  Earlier in his career, Saia was an attorney and special counsel at the U.S. Securities and Exchange Commission.

Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.